Tunlametinib Plus Vemurafenib in Patients with BRAF V600E-mutantNon-small Cell Lung Adenocarcinoma: A Case Report

Current Cancer Therapy Reviews · Published 2026-07-17 · DOI 10.2174/0115733947479817260710093848

Authors (2)

Xiaoqing Yu, Jian Hu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yu, X., Hu, J. (2026). Tunlametinib Plus Vemurafenib in Patients with BRAF V600E-mutantNon-small Cell Lung Adenocarcinoma: A Case Report. Current Cancer Therapy Reviews. https://doi.org/10.2174/0115733947479817260710093848

Related articles

• Advances in the Prevention and Treatment of Post-ESD Stricture in Early Esophageal Cancer · Current Cancer Therapy Reviews · 2026 · Same journal
• A Multi-study Meta-analysis Approach to Identifying Genetic Signatures in Lung Cancer Progression. · Current Cancer Therapy Reviews · 2025 · Same journal
• Recent Advancements in Revolutionizing Cancer Therapy with Liposomal Drug Delivery · Current Cancer Therapy Reviews · 2025 · Same journal
• Phytochemicals in Cancer Therapy: Unleashing the Healing Power of Herbs · Current Cancer Therapy Reviews · 2025 · Same journal
• Immunotherapy: Revolutionizing the Therapy of Glioblastoma · Current Cancer Therapy Reviews · 2026 · Same journal
• Verbascum sinuatum and Nisin Probiotics Promote Apoptosis and Inhibit Metastasis by Up-regulation of p53 and Caspase 9 and Down-regulation ofMMP9 and SUR · Current Cancer Therapy Reviews · 2026 · Same journal
• Causal Association between Genetically Predicted Telomere Length and Breast Cancer Risk: A Bidirectional Two-sample Mendelian Randomization Study · Current Cancer Therapy Reviews · 2026 · Same journal
• Cannabis in Recurrent Epithelial Ovarian Cancer: A Case Report · Current Cancer Therapy Reviews · 2025 · Same journal
• A Comprehensive Review of Risk Factors, Diagnosis, and Treatment Options for Oral Squamous Cell Carcinoma · Current Cancer Therapy Reviews · 2025 · Same journal
• Unravelling the Diabetes-cancer Nexus: An Interlinking Disease with Risk Factors, Screening, Management, Treatments, and Challenges · Current Cancer Therapy Reviews · 2026 · Same journal